Tonabersat

DRUG5 trials

Sponsors

Minster Research Ltd, Jaeb Center for Health Research, Inflammx Therapeutics Inc

Conditions

Diabetic Macular EdemaLong COVIDMigraine With AuraMigraine Without Aura

Phase 2

Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

CompletedNCT00311662

Minster Research LtdMigraine With Aura, Migraine Without Aura

Start: 2006-04-30End: 2006-10-31Updated: 2009-08-31

Tonabersat in the Prophylaxis of Migraine With Aura

CompletedNCT00332007

Minster Research LtdMigraine With Aura

Start: 2006-05-31End: 2008-08-31Updated: 2009-08-31

Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

CompletedNCT00534560

Minster Research LtdMigraine With Aura, Migraine Without Aura

Start: 2007-10-31End: 2009-03-31Updated: 2009-03-31

Evaluation of Tonabersat for DME

Active, not recruitingNCT05727891

Jaeb Center for Health ResearchDiabetic Macular Edema

Start: 2023-05-02End: 2026-01-31Target: 128Updated: 2025-12-11

Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

CompletedNCT06437223

Inflammx Therapeutics IncLong COVID

Start: 2024-03-12End: 2025-09-30Updated: 2026-03-06

Related Papers

Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.

2009-06-29113 citations